These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24544426)

  • 1. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS; AMSTERDAM D
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA; RANDALL E; THUM L; BARKER LF
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial susceptibility to antibiotics. V. Relative susceptibility of staphylococci and enterococci to erythromycin, carbomycin and a combination of chlortetracycline and chloramphenicol.
    EISENBERG GM; FLIPPIN HF; O'LOUGHLIN JM
    Antibiot Chemother (Northfield); 1953 Oct; 3(10):1026-8. PubMed ID: 24542703
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin, a new antibiotic. II. In vitro antibacterial studies.
    MCGUIRE JM; WOLFE RN; ZIEGLER DW
    Antibiot Annu; 1955-1956; 3():612-8. PubMed ID: 13355337
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
    ELLIOTT HJ; HALL WH
    J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
    [No Abstract]   [Full Text] [Related]  

  • 6. Novobiocin and PA 105: in vitro and in vivo studies on effectiveness against Micrococcus pyogenes.
    NOYES HE; NAGLE SC; SANFORD JP; ROBBINS ML
    Antibiot Chemother (Northfield); 1956 Jul; 6(7):450-5. PubMed ID: 24544026
    [No Abstract]   [Full Text] [Related]  

  • 7. Origin of erythromycin-resistant strains of Micrococcus pyogenes in infections; bacteriophage types and in vitro resistance of cultures to antibiotics.
    WISE RI; VOIGT AE; COLLIN MV; CRANNY CL
    AMA Arch Intern Med; 1955 Mar; 95(3):419-26. PubMed ID: 14349420
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro sensitivity of 300 strains of Micrococcus pyogenes isolated from carriers to seven antibiotics; the problem of the resistant Staphylococci in Chile.
    PAREDES L; VACCARO H; VALENZUELA E
    Antibiot Annu; 1955-1956; 3():623-33. PubMed ID: 13355339
    [No Abstract]   [Full Text] [Related]  

  • 9. The in vitro antibiotic activity of novobiocin on M. pyogenes and some intestinal gram-negative bacteria.
    COPPO A
    Antibiot Chemother (Northfield); 1957 Jun; 7(6):297-305. PubMed ID: 24544434
    [No Abstract]   [Full Text] [Related]  

  • 10. The participation of novobiocin and vancomycin in combined antibiotic action against staphylococci.
    BERTIE W; JAWETZ E; SONNE M
    Antibiotic Med Clin Ther (New York); 1957 Jan; 4(1):40-4. PubMed ID: 13382115
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combined antibiotics on the in vitro emergence of staphylococci resistant to novobiocin.
    CORIELL LL; LIN FK
    Antibiotic Med Clin Ther (New York); 1957 Jan; 4(1):35-9. PubMed ID: 13382114
    [No Abstract]   [Full Text] [Related]  

  • 13. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY; NUSSER W; EPSTEIN S; VAN MAREN H; OZOG S
    Antibiot Chemother (Northfield); 1958 Dec; 8(12):607-14. PubMed ID: 24545054
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance characteristics in hospital material, with special reference to staphylococcic and enterococcic sensitivity to erythromycin].
    KYLIN O
    Sven Lakartidn; 1956 Sep; 53(36):2259-67. PubMed ID: 13360709
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M; JONES WF; NICHOLS RL
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the sensitivity of bacteria to combinations of antibiotics in vitro; discussion of some results, especially with the combination tetracyclin-erythromycin.
    OSKAM HJ
    Acta Med Scand; 1956 Oct; 155(5):335-51. PubMed ID: 13372188
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of fixed combinations of antibiotics on Staphylococci in vitro.
    FURESZ S; ZANGAGLIA O; SCOTTI R
    Antibiot Chemother (Northfield); 1958 Nov; 8(11):571-5. PubMed ID: 24544980
    [No Abstract]   [Full Text] [Related]  

  • 18. [Constancy of the phenomenon of interference of mycetes with the antibacterial action of the new antibiotics].
    DI BELLA A
    Nuovi Ann Ig Microbiol; 1956; 7(1):65-70. PubMed ID: 13334990
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic combinations and resistance to antibiotics: penicillin with other antibiotics against penicillin-resistant staphylococci.
    FINLAND M; WILCOX C
    Proc Soc Exp Biol Med; 1953 Jul; 83(3):605-8. PubMed ID: 13088924
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptonivicin: laboratory and clinical studies in the pediatric age group.
    CORIELL LL; LIN FK
    Antibiot Annu; 1955-1956; 3():634-9. PubMed ID: 13355340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.